Skip to content

A Study on the Commonness of Amlapitta hyperacidity among Patients with High Blood Pressure.

A Cross Sectional Study on Prevalence of Amlapitta in Patients of Essential Hypertension with special reference to Nidanarthakarroga - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/102160
Enrollment
88
Registered
2026-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Nil: Nil

Sponsors

BALU BHAUJI MUNJANKAR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 30 to 60 years having systolic BP140 mm of Hg and diastolic BP 90 mm of Hg Both genders will be included irrespective of socioeconomic status Newly diagnosed and chronic cases of essential hypertension.

Exclusion criteria

Exclusion criteria: Patients aged below 30 years or above 60 years Patients with Secondary Hypertension Renal Endocrine Pregnant and Lactating women Patients with Diabetes mellitus Individuals with menopausal syndromes Patients with Congenital heart disease Patients other than essential hypertension Patients not willing to participate in this study

Design outcomes

Primary

MeasureTime frame
To estimate the prevalence of Amlapitta in patients of Essential Hypertension w.s.r to NidanarthakarrogaTimepoint: Cross sectional at single time point

Secondary

MeasureTime frame
1 To Estimate the prevalence of Amlapitta in the patients diagnosed with Essential Hypertention 2 To Study Amlapitta as a Nidanarthakarroga of Essential HypertensionTimepoint: Cross sectional Single time point

Countries

India

Contacts

Public ContactBALU BHAUJI MUNJANKAR

Government Ayurved College and Hospital,Nagpur

vdpranali@gmail.com9867351304

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026